Researchers from MIT and Scripps have unveiled a promising new HIV vaccine approach that generates a powerful immune response ...

The approach employed by the research team could be used against other diseases—including COVID-19 and influenza.

Health authorities in Zambia have halted a planned clinical trial for an HIV vaccine after the United States withdrew funding ...

By C.J. Atkins Just in time for Pride month, President Donald Trump and Health Secretary Robert F. Kennedy, Jr., have ...

Groundbreaking single-dose vaccine found effective in preventing HIV - Strategy may lead to new vaccines that only need to be ...

Researchers at MIT and the Scripps Research Institute have shown that they can generate a strong immune response to HIV with ...

The breakthrough double injection won’t be cheap in the US, although scientists argue it could (and should) be.

The US Food and Drug Administration (FDA) has approved use of the vaccine Yeztugo, manufactured by Gilead Sciences, is an anti-HIV drug.

In the quest to develop an effective HIV vaccine, scientists from Scripps Research have made a significant leap forward. They ...

Experts and advocates say that twice-a-year HIV PrEP injections have the prevention potential of a vaccine — and that a once-a-year version of lenacapavir would be even better. But will Yeztugo be ...

There is still no cure or effective vaccine for HIV, but scientists have opened up new possibilities in HIV treatment and ...

Immuno Cure Biotech Ltd. is collaborating with Pharmajet Inc. to evaluate the safety and immunogenicity of its HIV ...